We use cookies to ensure that we give you the best experience on our website. By continuing to use our site, you are agreeing to our use of cookies. You can change your cookie settings at any time if you want. Find out more in our privacy and cookies policy.
The latest news and research from the world of cystic fibrosis, keeping you up-to-date and in the know.
1-8 of 81 results for all news
The UK CF Registry will be taking a pivotal role in monitoring the effectiveness of Orkambi and Symkevi once they are in the hands of people...
Today Vertex Pharmaceuticals has announced that the European Medicines Agency (EMA) has validated a marketing-authorisation application for the...
The Department of Health in Northern Ireland has today confirmed its intention to complete a deal with Vertex Pharmaceuticals to make life-saving...
NHS England has today announced that people with cystic fibrosis (CF) living in England who stand to benefit from life-saving drugs Orkambi and...
The Scottish Government has announced a new interim deal that will see access to Orkambi and Symkevi for everyone with cystic fibrosis (CF) in...
Following last week’s rally, Carlie, a long-time campaigner with cystic fibrosis (CF), spoke to Dr Jeffery Leiden, Chief Executive of Vertex...
Analysis of UK CF Registry data found that people with cystic fibrosis (CF) taking ivacaftor (brand name Kalydeco) appear to have fewer lung...
The Scottish Medicines Consortium (SMC) have not been able to recommend the routine use of cystic fibrosis drugs Orkambi and Symkevi by NHS Scotland...